SCHEMBL20635141

SCHEMBL20635141

CC(C)c1cccc(C(C)C)c1NC(=O)NS(=O)(=O)C1CC(=O)N(CC(F)(F)F)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22433132 0.90 — —
SCHEMBL20635082 0.90 MEN1 (0.43) —
SCHEMBL20635148 0.89 GSTO1 (0.35) —
SCHEMBL20635145 0.89 NLRP3 (0.41) —
SCHEMBL22433298 0.85 — —
SCHEMBL22433443 0.84 — —
SCHEMBL22433579 0.83 — —
SCHEMBL20635147 0.82 NLRP3 (0.48) —
SCHEMBL20635801 0.82 MEN1 (0.46) —
SCHEMBL20635139 0.81 NLRP3 (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230037255-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LTD (IE) 2023-02-02 — — US disclosed
US-20200291003-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS SYGNATURE DISCOVERY LIMITED (GB) 2020-09-17 — — US disclosed
WO-2019008025-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LIMITED (IE) 2019-01-10 — — WO disclosed
Send feedback